Most people with gastroesophageal reflux disease reach the same frustrating juncture eventually. Proton pump inhibitors control the symptoms adequately for months, then less adequately, then require higher doses, then produce side effects from prolonged use, then begin to control the acid but not the regurgitation, not the laryngeal symptoms, not the nighttime awakening. PPIs suppress acid production. They do not fix the underlying mechanical problem, which is a lower oesophageal sphincter that fails to prevent reflux of gastric contents into the oesophagus.
When the mechanical problem is significant enough, no amount of acid suppression eliminates the symptoms completely, and indefinite PPI use carries its own risks including osteoporosis, hypomagnesaemia, C. difficile susceptibility, and, with very long-term use, potential kidney effects.
For international patients who have reached this point, gastroesophageal reflux disease treatments in India now include the full spectrum of endoscopic and surgical options that address the mechanical cause rather than just suppressing the acid, at NABH and JCI-accredited gastroenterology and surgical centres at 60 to 80 percent lower cost than Western equivalents.
Why Medication Alone Is Often Insufficient for GERD
GERD arises from the failure of the lower oesophageal sphincter (LES) and the gastro-oesophageal junction (GOJ) to act as an effective one-way valve, allowing gastric contents acid, bile, and pepsin to reflux into the oesophagus. The degree of this mechanical failure determines how much symptoms will persist despite medical management.
When PPIs Are Sufficient and When They Are Not
PPIs are effective for reducing acid-mediated symptoms including heartburn, epigastric pain, and acid-induced oesophagitis. They are appropriate as long-term treatment for patients with mild to moderate GERD without hiatal hernia, without significant regurgitation, and without complications.
PPIs are insufficient when:
-
Regurgitation of non-acid gastric contents is the dominant symptom, because PPIs reduce acid but do not stop reflux volume.
-
A large hiatal hernia mechanically displaces the GOJ above the diaphragm, preventing the diaphragmatic crural compression that contributes to sphincter function.
-
Barrett's oesophagus has developed, requiring not just acid suppression but mechanical prevention of ongoing reflux to reduce progression risk.
-
Laryngopharyngeal reflux (LPR) symptoms including hoarseness, chronic cough, and throat clearing persist despite optimal PPI dosing.
-
Quality of life remains significantly impaired despite adequate acid suppression.
The 2025 Evidence on Long-Term PPI Risks
The 2025 American College of Gastroenterology guideline update confirms that while PPIs are generally safe for long-term use, concerns remain about prolonged use including associations with hypomagnesaemia, vitamin B12 malabsorption, increased susceptibility to enteric infections, and potential kidney effects with very long-term use. These risks, combined with the failure to address the underlying mechanical cause, make surgical and endoscopic alternatives increasingly relevant for appropriate patients.
Investigating GERD Before Choosing Treatment
Before any non-medical intervention, a structured investigation confirms the diagnosis, characterises the severity of the mechanical failure, and identifies the presence of complications.
Key Investigations
-
Upper GI endoscopy (OGD): Assesses oesophageal mucosal damage (erosive versus non-erosive reflux disease), Barrett's oesophagus, hiatal hernia size, and the competence of the GOJ. Essential before any anti-reflux procedure.
-
24-hour ambulatory pH-impedance monitoring: The gold standard for confirming pathological acid and non-acid reflux. Impedance monitoring detects reflux regardless of acidity, which is important when symptoms persist on PPIs.
-
High-resolution oesophageal manometry: Assesses LES resting pressure, LES relaxation, and oesophageal body peristaltic function. Essential before anti-reflux surgery to identify oesophageal dysmotility, which changes the surgical approach.
-
Barium swallow: Characterises hiatal hernia anatomy and identifies oesophageal strictures.
These investigations are available at India's leading gastroenterology centres at a fraction of Western costs, and completing them before any interventional decision is the foundation of appropriate treatment selection.
Gastroesophageal Reflux Disease Treatments in India: The Full Spectrum
Treatment 1: Laparoscopic Nissen Fundoplication
Laparoscopic Nissen fundoplication is the gold standard surgical treatment for GERD and the most performed anti-reflux procedure globally. The surgeon wraps the upper portion of the stomach (fundus) 360 degrees around the lower oesophagus, recreating and reinforcing the LES, and repairs any hiatal hernia simultaneously.
The procedure is performed laparoscopically through five small incisions, with a hospital stay of two to three nights and return to normal activity within two to four weeks. Long-term success rates exceed 90 percent at ten years in appropriately selected patients, with symptom resolution in the vast majority.
The key requirement for Nissen fundoplication is adequate oesophageal peristalsis confirmed on manometry. Patients with oesophageal dysmotility are at higher risk of post-operative dysphagia with a 360-degree wrap, and may be better served by a partial wrap (Toupet 270-degree posterior fundoplication).
Laparoscopic fundoplication in India costs Rs. 1,20,000 to Rs. 2,50,000 (USD 1,450 to USD 3,000), compared to USD 10,000 to USD 25,000 in the USA, at NABH-accredited surgical gastroenterology centres with experienced laparoscopic surgeons.
Treatment 2: LINX Magnetic Sphincter Augmentation
The LINX device is a laparoscopically implanted ring of small magnetic titanium beads placed around the lower oesophageal sphincter. The magnetic attraction between the beads maintains LES closure at rest, preventing reflux. When the patient swallows, the bolus pressure overcomes the magnetic force, the ring opens, and food passes normally into the stomach. Belching and vomiting are also preserved because the magnetic force can be overcome by gastric pressure.
LINX is approved by the FDA and CE mark and represents an important advance for patients who want a less invasive alternative to fundoplication, particularly those who are concerned about post-operative gas bloat and the inability to belch after a full Nissen wrap. It requires no stomach wrapping and produces a smaller operative footprint.
Efficacy at five years shows over 85 percent of patients achieving greater than 50 percent reduction in PPI use, with significant improvement in all GERD symptom scores. LINX is contraindicated in patients with significant hiatal hernia (greater than three centimetres), oesophageal motility disorders, and those with MRI requirements (the device is MRI conditional only below 1.5 Tesla).
LINX is available at select advanced laparoscopic surgery centres in India at costs substantially below Western pricing.
Treatment 3: Transoral Incisionless Fundoplication (TIF)
TIF is a fully endoscopic anti-reflux procedure performed through the mouth, with no external incisions. Using the EsophyX device, the surgeon creates a partial anterior fundoplication from inside the stomach using polypropylene fasteners that reconstruct the gastro-oesophageal valve and restore the anatomy of the anti-reflux barrier.
TIF is the most appropriate option for:
-
Patients with GERD without a large hiatal hernia (greater than two centimetres)
-
Patients who prefer a completely incision-free procedure
-
Patients who have failed PPI therapy but are not ideal surgical candidates
-
Patients with persistent atypical GERD symptoms including LPR despite medical therapy
A 2025 systematic review and meta-analysis of TIF outcomes in 3,226 patients confirmed significant improvement in GERD health-related quality of life, significant reduction in regurgitation scores, significant DeMeester score reduction, and significant reduction in PPI use at two years. TIF is not as durable as laparoscopic fundoplication for the most severe GERD but provides a meaningful step up for patients with mild to moderate mechanical incompetence.
TIF is available at India's leading advanced endoscopy centres at significantly lower cost than in the USA or UK.
Treatment 4: Radiofrequency Energy Delivery (Stretta Procedure)
The Stretta procedure uses radiofrequency energy delivered through an endoscopically placed catheter to the LES muscle, creating controlled thermal lesions that increase LES muscle bulk and reduce LES compliance. It does not reconstruct the anti-reflux barrier but reduces the frequency and severity of transient LES relaxations (TLESRs), which are the primary mechanism of reflux in many GERD patients.
Stretta is the least invasive intervention and is performed entirely endoscopically without any incision or device implantation. A 2023 updated systematic review confirmed significant improvement in GERD symptoms, HRQoL scores, and PPI usage at 12 months, with a safety profile superior to surgical approaches. It is most appropriate for patients with documented pathological acid reflux who want to reduce PPI dependence without surgery.
Stretta is available at select advanced endoscopy centres in India.
Treatment 5: Robotic Fundoplication
For centres with advanced robotic surgical capability, robotic Nissen or Toupet fundoplication uses the da Vinci surgical system to perform the same anatomical reconstruction as standard laparoscopic fundoplication with enhanced precision. Robotic assistance provides 3D magnified vision and wristed instrument movement that some surgeons find advantageous for dissection of the hiatal anatomy and precise wrap calibration. Outcomes data comparing robotic and laparoscopic fundoplication show equivalent long-term results, with some studies showing lower conversion rates with robotic assistance.
Robotic fundoplication is available at select NABH and JCI-accredited surgical centres in India.
Comparing the Options: Which Treatment for Which Patient?
| Feature | Nissen fundoplication | LINX | TIF | Stretta |
|---|---|---|---|---|
| Approach | Laparoscopic | Laparoscopic | Endoscopic | Endoscopic |
| Hiatal hernia | Repaired simultaneously | Suitable for small hernia only | Suitable for small hernia only | Not appropriate for hernia |
| Ability to belch/vomit | Reduced | Preserved | Partially preserved | Preserved |
| Long-term durability | Highest (90%+ at 10 years) | 85%+ at 5 years | Moderate | Moderate |
| MRI restriction | None | Yes (conditional) | None | None |
| Best for | Significant GERD with or without hernia | GERD without large hernia, active patients | GERD without large hernia, minimally invasive preference | Mild-moderate GERD, PPI reduction goal |
Why International Patients Choose India for GERD Surgery
India's gastroenterology and surgical centres offer the full GERD treatment spectrum at NABH-accredited institutions with experienced laparoscopic and endoscopic gastroenterology teams.
Cost Comparison
| Procedure | India cost | USA equivalent |
|---|---|---|
| 24-hour pH-impedance monitoring | Rs. 8,000 to Rs. 15,000 (USD 96 to USD 180) | USD 1,500 to USD 3,500 |
| High-resolution oesophageal manometry | Rs. 5,000 to Rs. 10,000 (USD 60 to USD 120) | USD 1,000 to USD 2,500 |
| Laparoscopic Nissen fundoplication | Rs. 1,20,000 to Rs. 2,50,000 (USD 1,450 to USD 3,000) | USD 10,000 to USD 25,000 |
| LINX implantation | Rs. 2,50,000 to Rs. 5,00,000 (USD 3,000 to USD 6,000) | USD 15,000 to USD 30,000 |
| TIF procedure | Rs. 1,50,000 to Rs. 3,00,000 (USD 1,800 to USD 3,600) | USD 8,000 to USD 20,000 |
| Stretta procedure | Rs. 80,000 to Rs. 1,50,000 (USD 960 to USD 1,800) | USD 5,000 to USD 12,000 |
For patients who also need Barrett's oesophagus surveillance or endoscopic treatment alongside GERD management, read: How to Find the Best Endoscopy Centre in Kolkata Before Traveling to India For patients whose GERD symptoms overlap with IBD symptoms requiring a gastroenterology second opinion, read: Getting a Second Opinion for Inflammatory Bowel Disease (IBD) Treatment in India
How Karetrip Connects International GERD Patients to the Right Treatment in India
Two patients with failed PPI therapy may need completely different interventions based on their hiatal hernia size, oesophageal motility, and degree of mechanical LES failure. Karetrip reviews each patient's existing investigation results before recommending a treatment centre and approach in India, ensuring the proposed intervention matches the specific anatomy and physiology of the patient's GERD rather than defaulting to the most commonly performed procedure.
From pre-travel investigation review and medical visa coordination, through accommodation near the treating hospital and discharge documentation for dietary and activity guidance during recovery at home, Karetrip manages the complete international patient journey for gastroesophageal reflux disease treatments in India.
Chat with our Medical care assistant, RUA, for quick guidance and support and take the first step toward a GERD treatment that addresses the mechanical cause rather than suppressing its symptoms indefinitely.